Tuesday, November 18, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Pony AI Shares Continue Their Steep Descent

Andreas Sommer by Andreas Sommer
November 18, 2025
in Analysis, Automotive & E-Mobility, Nasdaq, Tech & Software, Trading & Momentum
0
Pony AI Stock
0
SHARES
20
VIEWS
Share on FacebookShare on Twitter

The autonomous mobility company Pony AI is witnessing a relentless sell-off in its shares, which fell nearly 6% in the latest session to close at $12.22. For ten consecutive trading days, the stock’s trajectory has been singular: a sharp and sustained decline.

All Eyes on the November 25 Report

The upcoming quarterly report, scheduled for November 25, is now the focal point for the embattled stock. The Q3 results are anticipated to be a decisive factor, potentially determining the next directional move. While the fundamental business data will be under intense scrutiny, the current technical outlook remains decidedly negative.

This persistent downturn is happening despite significant corporate achievements. In a landmark decision, Pony AI became the first company to receive approval for fully driverless robotaxi services across all four of China’s Tier-1 cities at the end of October. However, this regulatory milestone failed to alter the stock’s downward momentum. Similarly, market rumors concerning acquisition talks with Uber for its U.S. subsidiary provided only fleeting relief, failing to spark a lasting recovery.

Should investors sell immediately? Or is it worth buying Pony AI?

Technical Indicators Paint a Grim Picture

The scale of the recent decline is severe, with the company’s market value eroding by 30% over a mere two-week period. Yesterday’s trading highlighted the deep-seated uncertainty, as the stock swung in a range exceeding 12% between its daily high and low before settling significantly lower.

A look at the chart reveals a concerning setup:
* A clear bearish signal is present, with the 20-day moving average trading well below the 60-day average.
* Key resistance levels at $17.98 and $20.10 now appear distant and difficult to reclaim.
* Critical support zones are looming dangerously close at $11.11 and $8.98, levels that may soon be tested if the selling pressure continues.

A Critical Juncture for Investors

With the stock down over 30% in just ten trading sessions, the stakes for the next earnings report are exceptionally high. The market has already delivered its preliminary verdict through this aggressive price action. The burden is now on Pony AI to demonstrate with its Q3 figures that it is on the cusp of a commercial breakthrough, thereby justifying a potential reversal. For investors, the pressing question is no longer if the stock will fall further, but rather how much deeper the decline will go before finding a solid foundation.

Ad

Pony AI Stock: Buy or Sell?! New Pony AI Analysis from November 18 delivers the answer:

The latest Pony AI figures speak for themselves: Urgent action needed for Pony AI investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 18.

Pony AI: Buy or sell? Read more here...

Tags: Pony AI
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Aclaris Therapeutics Stock
Analysis

Aclaris Therapeutics Stock: Poised for a Breakout Year?

November 18, 2025
Ionis Stock
Analysis

Ionis Shares Surge on Strong Financials and Clinical Breakthroughs

November 18, 2025
SunHydrogen Stock
Hydrogen

SunHydrogen’s Green Hydrogen Technology Nears Commercial Reality

November 18, 2025
Next Post
Motorola Stock

Legal Storm Clouds Gather Over Motorola Shares

Albemarle Stock

Albemarle Stock: Signs of Life Return to Lithium Sector

Tilray Stock

Tilray Shares Plunge Following Strategic Overhaul Announcement

Recommended

General Electric Stock

GE Aerospace Stock Soars to Unprecedented Heights on Strategic Deals and Analyst Confidence

2 months ago
Ecolab Stock

Ecolab Stock: Mixed Earnings Trigger Analyst Debate

4 months ago
Financing chart

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

2 years ago
Strategy Stock

MicroStrategy’s European Debut Exceeds Capital Raising Expectations

1 week ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Absci’s Financial Crossroads: Can Pipeline Progress Offset Mounting Losses?

Shareholder Clash Intensifies Over Tiptree’s Billion-Dollar Divestiture

Akero Therapeutics Faces Critical Deadline Amid Acquisition Scrutiny

Rumble’s High-Stakes AI Pivot: Can a Failing Video Platform Reinvent Itself?

Supernus Maintains Full-Year Outlook Amid Ongoing Losses

Mercury Systems Stock: Analysts Bullish on Defense Technology Firm

Trending

Aclaris Therapeutics Stock
Analysis

Aclaris Therapeutics Stock: Poised for a Breakout Year?

by Dieter Jaworski
November 18, 2025
0

Investor attention turned to Aclaris Therapeutics this week following the company's presentations at the Jefferies Global Healthcare...

Ionis Stock

Ionis Shares Surge on Strong Financials and Clinical Breakthroughs

November 18, 2025
SunHydrogen Stock

SunHydrogen’s Green Hydrogen Technology Nears Commercial Reality

November 18, 2025
Absci Stock

Absci’s Financial Crossroads: Can Pipeline Progress Offset Mounting Losses?

November 18, 2025
Tiptree Stock

Shareholder Clash Intensifies Over Tiptree’s Billion-Dollar Divestiture

November 18, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Aclaris Therapeutics Stock: Poised for a Breakout Year?
  • Ionis Shares Surge on Strong Financials and Clinical Breakthroughs
  • SunHydrogen’s Green Hydrogen Technology Nears Commercial Reality

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com